Real-World study tracks quality of life in men on prostate cancer drug lutathera

NCT ID NCT06517719

Recruiting now Knowledge-focused Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 14, 2026 · Updated 3 times

Summary

This study follows 500 men with metastatic castration-resistant prostate cancer who are receiving lutetium-177 vipivotide tetraxetan (a radioactive drug) as part of their routine care. Researchers will measure quality of life, pain, and disease progression over time using patient questionnaires and medical records. The goal is to understand how this treatment works in real-world settings, outside of clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: lutetium-177 vipivotide tetraxetan (a radioactive drug that targets prostate cancer cells)
What this could lead to: If successful, this study will provide real-world data on how this treatment affects quality of life and disease progression in everyday practice.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient selection and other treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

castration-resistant prostate carcinoma metastatic prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

Contacts and locations

Locations

Novartis Investigative Site
RECRUITING

Konstanz, Baden-Wurttemberg, 78464, Germany
Novartis Investigative Site
RECRUITING

Stuttgart, Baden-Wurttemberg, 70174, Germany
Novartis Investigative Site
RECRUITING

Munich, Bavaria, 81377, Germany
Novartis Investigative Site
RECRUITING

Regensburg, Bavaria, 93053, Germany
Novartis Investigative Site
RECRUITING

Würzburg, Bavaria, 97080, Germany
Novartis Investigative Site
RECRUITING

Cottbus, Brandenburg, 03048, Germany
Novartis Investigative Site
RECRUITING

Frankfurt (Oder), Brandenburg, 15236, Germany
Novartis Investigative Site
RECRUITING

Ludwigshafen, Germany, 67063, Germany
Novartis Investigative Site
RECRUITING

Marburg, Hesse, 35043, Germany
Novartis Investigative Site
RECRUITING

Cologne, North Rhine-Westphalia, 50937, Germany
Novartis Investigative Site
RECRUITING

Dresden, Saxony, 01307, Germany
Novartis Investigative Site
RECRUITING

Leipzig, Saxony, 04103, Germany
Novartis Investigative Site
RECRUITING

Halle, Saxony-Anhalt, 06120, Germany
Novartis Investigative Site
RECRUITING

Jena, Thuringia, 07740, Germany
Novartis Investigative Site
RECRUITING

Aachen, 52074, Germany
Novartis Investigative Site
RECRUITING

Augsburg, 86179, Germany
Novartis Investigative Site
RECRUITING

Berlin, 10249, Germany
Novartis Investigative Site
RECRUITING

Berlin, 12559, Germany
Novartis Investigative Site
RECRUITING

Berlin, 13125, Germany
Novartis Investigative Site
RECRUITING

Bielefeld, 33611, Germany
Novartis Investigative Site
RECRUITING

Bonn, 53105, Germany
Novartis Investigative Site
RECRUITING

Braunschweig, 38114, Germany
Novartis Investigative Site
RECRUITING

Chemnitz, 09113, Germany
Novartis Investigative Site
RECRUITING

Dortmund, 44137, Germany
Novartis Investigative Site
RECRUITING

Dortmund, 44309, Germany
Novartis Investigative Site
RECRUITING

Erfurt, 99089, Germany
Novartis Investigative Site
RECRUITING

Erlangen, 91054, Germany
Novartis Investigative Site
RECRUITING

Essen, 45147, Germany
Novartis Investigative Site
RECRUITING

Fulda, 36043, Germany
Novartis Investigative Site
RECRUITING

Herford, 32049, Germany
Novartis Investigative Site
RECRUITING

Homburg, 66421, Germany
Novartis Investigative Site
RECRUITING

Magdeburg, 39120, Germany
Novartis Investigative Site
RECRUITING

Mainz, 55131, Germany
Novartis Investigative Site
RECRUITING

Nuremberg, 90419, Germany
Novartis Investigative Site
RECRUITING

Rostock, 18057, Germany
Novartis Investigative Site
RECRUITING

Trier, 54290, Germany
Novartis Investigative Site
RECRUITING

Tübingen, 72076, Germany
Novartis Investigative Site
RECRUITING

Ulm, 89081, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.